Novel Therapies: Entering Uncharted Territory Global Hemophilia Report

Gene therapy, hemostatic rebalancing therapies, memetic therapies, and even factor replacement therapy are all currently being explored in clinical trials, but while these therapies are paving the way to historical treatment ease and efficacy, they are also sweeping the hemophilia community into uncharted territory of potentially new challenges that must be addressed. This episode explores the current state of novel therapy investigation in hemophilia. Contributors:
Dr. Maria Elisa Mancuso
Dr. Glenn Pierce
Dr. Steven Pipe
Dr. Lindsey George
Dr. Margareth Ozelo
Dr. Guy Young
Dr. Michael Recht
Dr. Rich Gorman
Mark Skinner
Luke Pembroke
 
Senior Advisor:
Dr. Donna DiMichele
Links to learn more:
Future Therapies - National Hemophilia Foundation 2021 clinical trials update: Innovations in hemophilia therapy Advances in the management of haemophilia: emerging treatments and their mechanisms Emerging drugs for hemophilia A: insights into phase II and III clinical trials Discussing investigational AAV gene therapy with hemophilia patients: A guide Hemophilia Clinical Trials - ClinicalTrials.gov Show Notes:
Featured Advertiser: Sanofi
Subscribe to BloodStream Media’s Global Hemophilia Report
Connect with the Global Hemophilia Report
Global Hemophilia Report on LinkedIn
Global Hemophilia Report on Twitter
Global Hemophilia Report on Facebook
Connect with BloodStream Media:
BloodStreamMedia.com
BloodStream on Facebook 
BloodStream on Twitter